Description
Pexidartinib (PLX-3397) is a capsule containing a small-molecule receptor tyrosine kinase (RTK) inhibitor targeting KIT, CSF1R, and FLT3, with potential antineoplastic activity.
Molecular Formula
C20H15ClF3N5
Smiles
FC(F)(F)C1CCC(CNC2CCC(CC3C[NH]C4NCC(Cl)CC34)CN2)CN1
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 7.7 mg/mL (18.43 mM), In vivo: Suspension. Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.DMSO: 45 mg/mL (107.7 mM)Ethanol: < 1 mg/mL (insoluble or slightly soluble)
Relative Density
1.458 (Predicted)